• Users Online: 197
  • Print this page
  • Email this page

 
Table of Contents
LETTER TO EDITOR
Year : 2022  |  Volume : 16  |  Issue : 2  |  Page : 239

Novel coronavirus disease in kidney-transplant recipients: Correspondence


1 Private Academic Consultant, Bangkok, Thailand
2 Department of Community Medicine, Dr. D.Y. Patil University, Pune, Maharashtra, India

Date of Submission26-Nov-2021
Date of Acceptance05-Apr-2022
Date of Web Publication30-Jun-2022

Correspondence Address:
Dr. Pathum Sookaromdee
Private Academic Consultant, Bangkok
Thailand
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijot.ijot_123_21

Rights and Permissions

How to cite this article:
Sookaromdee P, Wiwanitkit V. Novel coronavirus disease in kidney-transplant recipients: Correspondence. Indian J Transplant 2022;16:239

How to cite this URL:
Sookaromdee P, Wiwanitkit V. Novel coronavirus disease in kidney-transplant recipients: Correspondence. Indian J Transplant [serial online] 2022 [cited 2022 Aug 15];16:239. Available from: https://www.ijtonline.in/text.asp?2022/16/2/239/349370



Dear Editor,

We would like to share ideas on “Clinical characteristics and outcome of novel coronavirus disease in kidney transplant recipients: A single-center prospective observational study.”[1] Arumugam et al. concluded that “Our largest cohort of patients from India showed higher incidence of acute graft dysfunction and significant mortality in patients with COVID-19.”[1] This report can confirm problem of COVID-19 among transplant patients. An interesting observation is no association between background immunosuppression therapy and severity of disease. This might imply that the pathological process of COVID-19 in transplant case is mainly due to nonimmunological process. Regarding graft dysfunction, the cause is interesting. During COVID-19, there is significant rheological change,[2] and this might be an important factors leading to poor vascularization of graft and might related to graft rejection. Finally, mortality in COVID-19 case with underlying transplantation is an interesting issue for further studies. The present study gives some interesting observations, but there is no control; hence, the interpretation has to be careful. The mortality of COVID-19 depends on several factors including therapeutic management given to the patients. Further study with comparison to control group under the same therapeutic management might give more data on mortality in this issue.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Arumugam V, Sastry BV, Solomon DJ, Gopalakrishnan N, Kannan BS, Shankar P, et al. Clinical characteristics and outcome of novel coronavirus disease in kidney transplant recipients: A single-center prospective observational study. Indian J Transplant 2021;15:189-98.  Back to cited text no. 1
  [Full text]  
2.
Joob B, Wiwanitkit V. Blood viscosity of COVID-19 patient: A preliminary report. Am J Blood Res 2021;11:93-5.  Back to cited text no. 2
    




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
References

 Article Access Statistics
    Viewed80    
    Printed4    
    Emailed0    
    PDF Downloaded14    
    Comments [Add]    

Recommend this journal